Amyotrophic lateral sclerosis and spinocerebellar ataxia 2

Neurology

Volumn 76, Issue 24, 2011, Pages 2050-2051

  Fischbeck, Kenneth H ^a,c   Pulst, Stefan M ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c 35 2A1000 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; POLYGLUTAMINE; PROTEIN SPINOCEREBELLAR ATAXIA 2; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DYSFUNCTION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; KENNEDY DISEASE; MOTOR NEURON DISEASE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 79959636879     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821f4498     Document Type: Editorial

References (15)

1. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362: 59-62. (Pubitemid 23087289)
2. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-1672. (Pubitemid 351432505)
3. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-574. (Pubitemid 351601218)
4. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009;323: 1205-1208.
5. Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010;68:857-864.
6. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-394. (Pubitemid 36935331)
7. Van Vught PWJ, Sutedja NA, Veldink JH, et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 2005;65:1643-1645. (Pubitemid 41689483)
8. Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010;466:1069-1075.
9. Van Damme P, Veldink JH, van Blitterswijk M, et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 2011; 76:2066-2072.
10. Nanetti L, Fancellu R, Tomasello C, et al. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 2009;256:1926-1928.
11. Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000;55:800-805.
12. Parboosingh JS, Figlewicz DA, Krizus A, et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997;49:568-572. (Pubitemid 27368903)
13. van Es MA, Veldink JH, Saris CG, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 2009;41:1083-1087.
14. Lee T, Li YR, Chesi A, et al. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 2011;76:2062-2065.
15. Charles P, Camuzat A, Benammar N, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 2007;69:1970-1975. (Pubitemid 350145088)